Use the buttons below if you would like to share this info :

Registration Is Open!
Registration and information about the meeting here

Workshop on
Diagnostics in the Veterinary Field:
The Role in Health Surveillance and Disease Identification

A workshop focusing on advantages / benefits and disadvantages
and gaps of the current methods and methodologies

Meeting objectives
Diagnostics are an essential tool to ensure the health of domestic and wild animals for both endemic and emerging diseases.  They allow animal health professionals to understand and manage the general health status of domestic animals. They are also important tools to support public health initiatives in the case of zoonotic disease control. The meeting will provide an overview of existing systems and approaches / strategies for the use of diagnostics and to discuss the currently available diagnostics. The advantages / benefits and disadvantages / gaps of the current methods and methodologies will be identified and discussed. Proposals on how to increase the quality, efficacy, and utility of the existing strategies and methods and those under development will be made.

 
Scientific Committee

Sandra Blome, Friedrich Löffler Institut
Attila Farsang, CEVA
Cyril Gay, USDA
Richard Hill, IABS
Carmen Jungbäck, IABS, Chair
Vaughn Kubiak, Zoetis
Serge Leterme, IDEXX
David Mackay, EMA
Paul Midtlyng, University of Oslo
Egbert Mundt, Boehringer-Ingelheim
Amir Noormohammadi, University of Melbourne
Suelee Robbe-Austerman, APHIS-USDA
Sjaak de Wit, Deventer

Use the buttons below if you would like to share this info :

Towards Rabies Elimination in Asia-Pacific – From Theory to Practice

Registration and information about the meeting here

Meeting objectives
The meeting aims at snowballing efforts and achieving substantial progress in rabies control in the Asia-Pacific region of the world in the near future. As the key focus is placed on canine rabies the meeting will be an important contribution to the initiative of the United Against Rabies collaboration of the World Health Organization (WHO), World Organisation for Animal Health (OIE), Food and Agriculture Organization of the United Nations (FAO), and Global Alliance for Rabies Control (GARC) of ending human dog-mediated rabies by 2030. Recognized international and local experts will give insights into state-of-the art intersectoral One Health approaches, standards, available tools and guidelines developed by international organizations and institutions and best-practice examples from the region on how to prevent human rabies by eliminating rabies at its animal source. As such the meeting provides a platform for health and veterinary services, managers of national and local rabies eliminations programs, researchers and other people interested in advancing knowledge of rabies surveillance, prevention and control, to meet each other, to share their experience and also to discuss challenges to overcome. The meeting is considered to be a starting point for a continuous professional exchange on the way to a rabies free Asia-Pacific.

Scientific Committee :

Dr Charung Muangchana Director, National Veterinary Institute, Thailand
Dr Karoon Chanachai, Department of Livestock Development (DLD), Thailand
Dr Thomas Müller, Chair Friedrich-Loeffler-Institut, Germany
Dr Conrad Freuling, Friedrich-Loeffler-Institut, Germany
Dr Bernadette Abela-Ridder, World Healandh Organization
Dr Ivana Knezevic, World Health Organization
Dr Gregorio Torres, World Organization for Animal Health (OIE)
Dr Katinka de Balogh, Food and Agricultural Organization of the UN (FAO)
Dr Carmen Jungbäck, International Alliance for Biological Standardization (IABS)
Dr Gowri Yale, Mission Rabies
Prof. Louis Nel,Global Alliance for Rabies Control
Dr Ryan Wallace, Centres for Disease Control and Prevention, USA

Use the buttons below if you would like to share this info :

SAVE THE DATE

 Non-animal Testing of Vaccines - A Global Congress

Meeting objectives
IABS and Vac2Vac are honoured to be organizing a Global Congress that will focus on replacement of in vivo testing of vaccines by in vitro methods with utilization of new and improved technologies. Progresses made with analytical tools and their applications have contributed to development of fast, precise and highly reliable in vitro tests that will allow batch to batch release of vaccines by consistency approach. Recent case studies on specific vaccines will be reviewed, and ongoing as well as future studies on other vaccines will be discussed. A particular emphasis will be placed on global coordination in areas of manufacturing and testing practices, and regulatory acceptance, with the goal of reducing time to market and increasing global access to vaccines. Participation from all of these areas of vaccine development, especially from LMICs and GAVI countries, is strongly encouraged. Bangkok has been selected as the site for this Congress because of its location amid countries with emerging vaccine producers and growing needs for vaccines.

We are honoured to have pledges of support from global foundations and partners from emerging economies.

More information coming soon....

 

Use the buttons below if you would like to share this info :

SAVE THE DATE

3rd Human Challenge Trials in Vaccine Development

 More information about this meeting soon....

Use the buttons below if you would like to share this info :

SAVE THE DATE

Quality of Challenge Agent
An IABS-EU Meeting

Meeting Objectives
One of the proposed tools for faster development of new vaccines is CHIM: Controlled Human Infectious Models. These models can be used for early PoC (Proof of Concept) and as a basis for clinical  “Go/No Go” decisions, in particular if sporadic epidemiology impedes clinical development.
In these models researchers will use a challenge agent: a virus, bacterium or parasite. Frequently questions are raised on the quality of the agent. Should this agent be produced following GMP? What strain-related information is relevant?  Should it be attentuated or resemble the wild type?

These questions will be discussed during this symposium, more information will follow soon

 

 

Use the buttons below if you would like to share this info :

Registration Is Open!

2nd Next Generation Sequencing
for Adventitious Virus Detection

Meeting objectives
T
his meeting will focus on the current scientific data and knowledge related to the use of next generation sequencing technologies for adventitious virus detection in biological products. Discussions will include ongoing efforts and future needs toward standardization and validation of the technical and bioinformatics steps involved in NGS for its applications in characterization and safety evaluation of biologics, including human and animal vaccines. The meeting will bring together representatives from industry, academia, technology providers, and international regulatory bodies for developing a scientific consensus regarding readiness of NGS for detection of adventitious viruses in biologics.

ABSTRACT SUBMISSIONS

Abstracts will be considered for talks/posters.
Submission deadline: May 31, 2019.

Please send submission to This email address is being protected from spambots. You need JavaScript enabled to view it.
Subject: Abstract for 2nd IABS NGS meeting


The following topics related to NGS for human and veterinary biologics will be considered:
Sample preparation and processing
Standards and Standardization
Bioinformatics strategies and pipelines
Follow up of signals
Applications for adventitious virus testing in biologics
Virus discovery
Regulatory challenges

Scientific Committee

Dieter Deforce, Ghent University / Federal Agency for Medicines and Health Products of Belgium (FAMHP)
Sebastiaan Theuns, Ghent University
Arifa Khan, U.S. Food and Drug Administration (FDA)
Pieter Neels, International Alliance for Biological Standardization (IABS)
Sven Arnouts, Ghent University / PROVAXS
Johannes Blümel, Paul-Ehrlich Institut (PEI)
Bill Egan, Novartis Vaccines & Diagnostics
Carmen Jungbäck, International Alliance for Biological Standardization (IABS)
Ivana Knezevic, World Heath Organization (WHO)
Laurent Mallet, Sanofi Pasteur
Gerald Schumann, Paul-Ehrlich Institut (PEI)
Joseph Victoria, Boehringer-Ingelheim

Register Here

 More information about this IABS-EU meeting coming soon...

 

 

International Alliance for Biological Standardization


Twitter Feed

IABS #diagnosticsveterinary workshop. Topic: Diagnostic strategies for endemic diseases: surveillance and control. https://t.co/1IQgCcgxTk
IABS #diagnostics veterinary workshop. Topic: Modern antimicrobial sensitivity testing: current state of affairs an… https://t.co/shSM50OJ4c
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.